• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ⅱ型脊肌萎缩症患儿及成年患者长时间禁食引起的高酮血症、低血糖和脂肪氧化受损。

Prolonged fasting-induced hyperketosis, hypoglycaemia and impaired fat oxidation in child and adult patients with spinal muscular atrophy type II.

机构信息

Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

出版信息

Acta Paediatr. 2021 Dec;110(12):3367-3375. doi: 10.1111/apa.16074. Epub 2021 Aug 30.

DOI:10.1111/apa.16074
PMID:34407566
Abstract

AIM

This study explored hypoglycaemia and metabolic crises, including hyperketosis, in patients with spinal muscular atrophy (SMA).

METHODS

The study comprised four adolescents aged 15-17 and six adults aged 19-37 with SMA type II and eight adult controls aged 21-41, who were recruited by the Rigshospitalet, Denmark, from May 1st to October 30th 2017. We used stable isotope technique and indirect calorimetry to investigate fat and glucose metabolism during a 24-h fast or until hypoglycaemia occurred.

RESULTS

All patients with SMA II developed moderate to severe hyperketosis and 60% had symptoms of hypoglycaemia or blood glucose levels below 3 mmol/L. None of the controls developed hyperketosis or hypoglycaemia. Plasma bicarbonate decreased, in line with increased ketone bodies, indicating the start of metabolic acidosis in patients with SMA II. Increased fat production and utilisation were seen in healthy controls during the fasting period, but were absent in patients with SMA II, indicating blunted fat oxidation.

CONCLUSION

Low skeletal muscle mass was the best explanation for why patients with SMA II had an increased risk of hypoglycaemia, hyperketosis, metabolic acidosis and disturbed fat and glucose metabolism during fasting. These risks have implications for children facing surgery and those with severe illnesses.

摘要

目的

本研究探讨了肌萎缩侧索硬化症(SMA)患者的低血糖和代谢危象,包括酮症酸中毒。

方法

该研究纳入了 2017 年 5 月 1 日至 10 月 30 日期间,丹麦 Rigshospitalet 通过招募的 4 名 15-17 岁的青少年 SMA Ⅱ型患者和 6 名 19-37 岁的成年患者,以及 8 名 21-41 岁的成年对照组。我们使用稳定同位素技术和间接测热法来研究 24 小时禁食期间或直至发生低血糖时的脂肪和葡萄糖代谢情况。

结果

所有 SMA Ⅱ型患者均出现中重度酮症酸中毒,60%的患者出现低血糖症状或血糖水平低于 3mmol/L。对照组均未出现酮症酸中毒或低血糖。血浆碳酸氢盐减少,与酮体增加一致,表明 SMA Ⅱ型患者开始出现代谢性酸中毒。健康对照组在禁食期间会增加脂肪生成和利用,但 SMA Ⅱ型患者却没有,表明脂肪氧化受损。

结论

骨骼肌量低是 SMA Ⅱ型患者在禁食期间发生低血糖、酮症酸中毒、代谢性酸中毒以及脂肪和葡萄糖代谢紊乱风险增加的最佳解释。这些风险对面临手术的儿童和患有严重疾病的儿童具有重要意义。

相似文献

1
Prolonged fasting-induced hyperketosis, hypoglycaemia and impaired fat oxidation in child and adult patients with spinal muscular atrophy type II.Ⅱ型脊肌萎缩症患儿及成年患者长时间禁食引起的高酮血症、低血糖和脂肪氧化受损。
Acta Paediatr. 2021 Dec;110(12):3367-3375. doi: 10.1111/apa.16074. Epub 2021 Aug 30.
2
Hypoglycaemia in spinal muscular atrophy.脊髓性肌萎缩症中的低血糖症。
Lancet. 1995 Sep 2;346(8975):609-10. doi: 10.1016/s0140-6736(95)91439-0.
3
Hypoglycaemia in patients with type 1 SMA: an underdiagnosed problem?1型脊髓性肌萎缩症患者的低血糖症:一个诊断不足的问题?
Arch Dis Child. 2020 Jul;105(7):707. doi: 10.1136/archdischild-2019-318120. Epub 2019 Dec 20.
4
Responses to Fasting and Glucose Loading in a Cohort of Well Children with Spinal Muscular Atrophy Type II.II型脊髓性肌萎缩症健康儿童队列对禁食和葡萄糖负荷的反应
J Pediatr. 2015 Dec;167(6):1362-8.e1. doi: 10.1016/j.jpeds.2015.09.023. Epub 2015 Oct 9.
5
Paradoxical metabolic acidosis after vomiting in children with spinal muscular atrophy: A report of 9 patients.脊髓性肌萎缩症患儿呕吐后出现代谢性酸中毒悖论:9 例报告。
Arch Pediatr. 2024 Oct;31(7):451-454. doi: 10.1016/j.arcped.2024.03.010. Epub 2024 Sep 26.
6
Acetaminophen treatment in children and adults with spinal muscular atrophy: a lower tolerance and higher risk of hepatotoxicity.乙酰氨基酚治疗儿童和成人脊髓性肌萎缩症:耐受性降低和肝毒性风险增加。
Neuromuscul Disord. 2024 Jan;34:9-18. doi: 10.1016/j.nmd.2023.11.005. Epub 2023 Nov 15.
7
Executive function is inversely correlated with physical function: the cognitive profile of adult Spinal Muscular Atrophy (SMA).执行功能与身体功能呈负相关:成人脊髓性肌萎缩症(SMA)的认知概况。
Orphanet J Rare Dis. 2021 Jan 6;16(1):10. doi: 10.1186/s13023-020-01661-9.
8
Glucose and lipid metabolism disorders in children and adolescents with spinal muscular atrophy types 2 and 3.2 型和 3 型脊肌萎缩症患儿和青少年的糖脂代谢紊乱。
Neuromuscul Disord. 2021 Apr;31(4):291-299. doi: 10.1016/j.nmd.2021.02.002. Epub 2021 Feb 3.
9
A continuous repetitive task to detect fatigability in spinal muscular atrophy.一项用于检测脊髓性肌萎缩症疲劳性的连续重复任务。
Orphanet J Rare Dis. 2018 Sep 12;13(1):160. doi: 10.1186/s13023-018-0904-5.
10
Drug treatment for spinal muscular atrophy types II and III.脊髓性肌萎缩症II型和III型的药物治疗。
Cochrane Database Syst Rev. 2020 Jan 6;1(1):CD006282. doi: 10.1002/14651858.CD006282.pub5.

引用本文的文献

1
Paracetamol and its metabolites in children and adults with spinal muscular atrophy - a population pharmacokinetic model.脊髓性肌萎缩症儿童和成人中对乙酰氨基酚及其代谢物——一项群体药代动力学模型
Br J Clin Pharmacol. 2025 Jul;91(7):2045-2056. doi: 10.1002/bcp.70028. Epub 2025 Mar 4.
2
A Prospective Study on the Feasibility and Effect of an Optimized Perioperative Care Protocol in Pediatric Neuromuscular Scoliosis Surgery.优化围手术期护理方案在小儿神经肌肉型脊柱侧弯手术中的可行性及效果的前瞻性研究
J Clin Med. 2024 Dec 23;13(24):7848. doi: 10.3390/jcm13247848.
3
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy.
脊髓性肌萎缩症患者接受 nusinersen 治疗后的蛋白质组学分析和机器学习。
Cell Mol Life Sci. 2024 Sep 10;81(1):393. doi: 10.1007/s00018-024-05426-6.
4
SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy.运动神经元存活基因缺失会扰乱脊髓性肌萎缩症中的单胺神经递质代谢。
Commun Biol. 2023 Nov 13;6(1):1155. doi: 10.1038/s42003-023-05543-1.
5
Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy.依地膦酸奈酚在多发性骨髓瘤患者中的药代动力学特征及药物相互作用
Biomolecules. 2022 Oct 6;12(10):1431. doi: 10.3390/biom12101431.